Singapore markets open in 6 hours 21 minutes
Straits Times Index
3,303.19 +10.26 (+0.31%) S&P 500
5,168.75 +40.96 (+0.80%) Dow
38,833.81 +158.13 (+0.41%) Nasdaq
16,296.79 +140.46 (+0.87%) Bitcoin USD
63,409.86 -522.10 (-0.82%) CMC Crypto 200
1,361.61 +48.99 (+3.73%)
Aurinia Pharmaceuticals Inc. (AUPH)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 02:38PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 729.40M |
| Enterprise value | 476.52M |
| Trailing P/E | N/A |
| Forward P/E | 126.58 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 4.16 |
| Price/book (mrq) | 1.93 |
| Enterprise value/revenue | 2.71 |
| Enterprise value/EBITDA | -7.56 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.38 |
| 52-week change 3 | -53.80% |
| S&P500 52-week change 3 | 22.38% |
| 52-week high 3 | 12.43 |
| 52-week low 3 | 4.71 |
| 50-day moving average 3 | 5.23 |
| 200-day moving average 3 | 7.76 |
Share statistics
| Avg vol (3-month) 3 | 2.15M |
| Avg vol (10-day) 3 | 1.46M |
| Shares outstanding 5 | 143.02M |
| Implied shares outstanding 6 | 143.02M |
| Float 8 | 129.83M |
| % held by insiders 1 | 7.53% |
| % held by institutions 1 | 39.15% |
| Shares short (15 Apr 2024) 4 | 11.39M |
| Short ratio (15 Apr 2024) 4 | 8.02 |
| Short % of float (15 Apr 2024) 4 | 7.90% |
| Short % of shares outstanding (15 Apr 2024) 4 | 7.88% |
| Shares short (prior month 15 Mar 2024) 4 | 10.65M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -32.69% |
| Operating margin (ttm) | -13.06% |
Management effectiveness
| Return on assets (ttm) | -8.10% |
| Return on equity (ttm) | -16.69% |
Income statement
| Revenue (ttm) | 191.41M |
| Revenue per share (ttm) | 1.33 |
| Quarterly revenue growth (yoy) | 46.20% |
| Gross profit (ttm) | N/A |
| EBITDA | -47M |
| Net income avi to common (ttm) | -62.56M |
| Diluted EPS (ttm) | -0.54 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 319.37M |
| Total cash per share (mrq) | 2.24 |
| Total debt (mrq) | 88.54M |
| Total debt/equity (mrq) | 24.63% |
| Current ratio (mrq) | 5.61 |
| Book value per share (mrq) | 2.50 |
Cash flow statement
| Operating cash flow (ttm) | -20.39M |
| Levered free cash flow (ttm) | 14.53M |
© 2024 Yahoo. All rights reserved.